Kestra Medical Technologies Stock Sees 2.5% Increase - Is It Time to Invest?

Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) experienced a notable increase of 2.5% on Monday. The stock reached a high of $24.40 before settling at a last trading price of $24.01. During the day, approximately 80,622 shares changed hands, marking a significant drop of 73% from the average daily trading volume of 293,426 shares. The previous close for the stock was at $23.43.

Recent Analyst Ratings

Several equity research analysts have recently shared their perspectives on Kestra Medical Technologies. On Monday, Piper Sandler initiated coverage on the stock, providing an "overweight" rating along with a price target of $27.00. Additionally, Bank of America commenced coverage on Kestra Medical Technologies, issuing a positive "buy" rating and setting a target price of $30.00. Wolfe Research also began coverage, assigning an "outperform" rating with a price target of $29.00. Wells Fargo & Company followed suit, providing an "overweight" rating and a price target of $28.00. Finally, Stifel Nicolaus added their coverage, rating the stock as a "buy" with a corresponding target price of $28.00. Currently, one analyst has rated the stock with a hold, while five analysts have assigned it a buy rating. According to MarketBeat, this results in an overall average rating of "Moderate Buy" with an average price target set at $27.67.

About Kestra Medical Technologies

Kestra Medical Technologies is a commercial-stage company specializing in wearable medical devices and digital healthcare solutions. Their focus is on enhancing patient outcomes for those suffering from cardiovascular diseases. They accomplish this through innovative monitoring and therapeutic interventions that are both intuitive and connected. One of their flagship offerings is the Cardiac Recovery System platform, which provides an advanced and integrated solution that combines monitoring, therapeutic treatment, digital health, and patient support services.

Investment Consideration

If you’re contemplating an investment in Kestra Medical Technologies, it’s worth noting that while they hold a Moderate Buy rating, top analysts have identified five other stocks that may present better buying opportunities at this time.

Kestra, Stocks, Investment